75°
Feels Like: 75°
82°
67°
87°
By Kathryn Doyle NEW YORK (Reuters Health) - Most women expect hot flashes as a part of the "change of life," but more than half sta...
Read More »By Foo Yun Chee BRUSSELS (Reuters) - European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of 1...
Read More »By Ben Hirschler LONDON (Reuters) - AstraZeneca and Bristol-Myers Squibb's diabetes drug Onglyza failed to reduce heart risks in a l...
Read More »By Susan Kelly CHICAGO (Reuters) - Shares of U.S. hospital operators have been on a tear this year, on average posting triple the ga...
Read More »By P.J. Huffstutter CHICAGO (Reuters) - A swine virus deadly to young pigs, one never before seen in North America, is spreading rap...
Read More »By Ben Hirschler LONDON (Reuters) - Pharmaceutical companies need to boost the benefits of drug research by working with regulators ...
Read More »By Ransdell Pierson (Reuters) - The U.S. Food and Drug Administration is investigating the cases of two individuals who died after i...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - If a person doesn't have much success with one pain treatment, they may say the next...
Read More »By Jason McLure LITTLETON, New Hampshire (Reuters) - New Hampshire is set to become the final state in New England to allow medical ...
Read More »(Reuters) - A U.S. appeals court found the patent on Novo Nordisk's Prandin diabetes drug in combination with metformin to be invali...
Read More »
